Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leveraging an immune cell signature to improve the survival and immunotherapy response of lung adenocarcinoma. | J Cancer | 2024 | 38213728 | PubTator, text mining | PubMed |
| Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis. | J Cancer | 2024 | 38213717 | PubTator, text mining | PubMed |
| Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer. | BMC Genomics | 2024 | 38212708 | PubTator, text mining | PubMed |
| Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis. | J Allergy Clin Immunol Glob | 2024 | 38187863 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma. | Heliyon | 2024 | 38187284 | PubTator, text mining | PubMed |
| Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs. | Allergy | 2024 | 38186219 | PubTator, text mining | PubMed |
| Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside. | Signal Transduct Target Ther | 2024 | 38185721 | PubTator, text mining | PubMed |
| Isolation and characterization of a novel lytic Parabacteroides distasonis bacteriophage φPDS1 from the human gut. | Gut Microbes | 2024 | 38178369 | PubTator, text mining | PubMed |
| Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma. | Sci Rep | 2024 | 38177255 | PubTator, text mining | PubMed |
| Systematic analysis of the prognostic value and immunological function of LTBR in human cancer. | Aging (Albany NY) | 2024 | 38175686 | PubTator, text mining | PubMed |
| Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. | Theranostics | 2024 | 38169577 | PubTator, text mining | PubMed |
| Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma. | J Cancer | 2024 | 38169540 | PubTator, text mining | PubMed |
| Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis. | Nat Commun | 2024 | 38168103 | PubTator, text mining | PubMed |
| T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. | Nat Commun | 2024 | 38167722 | PubTator, text mining | PubMed |
| Path towards mRNA delivery for cancer immunotherapy from bench to bedside. | Theranostics | 2024 | 38164145 | PubTator, text mining | PubMed |
| Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. | Clin Cancer Res | 2024 | 38153346 | PubTator, text mining | PubMed |
| Differential expression of immune checkpoints (OX40/OX40L and PD-1/PD-L1) in decidua of unexplained recurrent spontaneous abortion women. | Hum Immunol | 2024 | 38142184 | PubTator, text mining | PubMed |
| Identification and validation of N7 -methylguanosine-associated gene NCBP1 as prognostic and immune-associated biomarkers in breast cancer patients. | J Cell Mol Med | 2024 | 38071502 | PubTator, text mining | PubMed |
| The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment. | Biosci Rep | 2024 | 38051200 | PubTator, text mining | PubMed |
| Comparative evaluation of antitumor effects of TNF superfamily costimulatory ligands delivered by mesenchymal stem cells. | Int Immunopharmacol | 2024 | 37995568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=14